Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using 2h-glycosuria Combined With Fasting Plasma Glucose , Advanced Glycation End-product Alone or in Combination With Fasting Plasma Glucose in Diabetes Screening in Chinese Natural Population

NCT03025919 is registered in ClinicalTrials.gov with Zhongda Hospital as lead sponsor.

NCT NCT03025919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03025919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using 2h-glycosuria Combined With Fasting Plasma Glucose , Advanced Glycation End-product Alone or in Combination With Fasting Plasma Glucose in Diabetes Screening in Chinese Natural Population
Lead sponsor
Zhongda Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2017
Completion date
December 31, 2017
Enrollment
20,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type ii diabetes mellitus